Supplement Regulations Across US, EU, Singapore, and Australia: 2026 Market Entry Guide

Global supplement expansion offers massive upside, and regulatory complexity to match.

Unlike conventional foods, supplements sit at the intersection of nutrition, health, and medicine. As a result, regulatory frameworks vary dramatically by market.

This guide breaks down what brands need to know to launch successfully across four major regions.

One Product, Four Rulebooks

• US: Flexible, post-market enforcement

• EU: Pre-market approval, high evidence bar

• Singapore: Classification-driven system

• Australia: Therapeutic goods framework

Assuming consistency across markets is the fastest way to fail.

United States: DSHEA Framework

Key Features

• Dietary Supplement Health and Education Act (DSHEA)

• Structure/function claims allowed

• New Dietary Ingredient (NDI) notifications required

Common Pitfalls

• Missing NDIs

• Overstated claims

• GMP documentation gaps

European Union: Novel Foods and EFSA

Key Features

• Novel Foods authorization

• EFSA-approved health claims only

• Country-level notifications

Risk Factors

• Ingredient novelty

• Claim rejection

• Lengthy approval timelines

Singapore: HSA Classification System

Key Features

• Health supplement vs therapeutic product distinction

• Ingredient-based classification

• Pre-market guidance encouraged

Why Brands Struggle

Misclassification can trigger unexpected therapeutic regulation.

Australia: TGA (AUST L vs AUST R)

Key Features

• Listed (AUST L) vs Registered (AUST R)

• Evidence thresholds tied to risk

• Strong post-market surveillance

Strategic Implications

Positioning determines regulatory burden.

Timelines, Cost and Complexity by Market

90-Day Roadmap to Multi-Market Launch

Days 1 to 30

• Ingredient and claim classification

• Market prioritization

Days 31 to 60

• Documentation and evidence prep

• Regulatory consultations

Days 61 to 90

• Notifications and approvals

• Label finalization

Final Thought

Successful supplement brands design products with regulatory scalability in mind, not as an afterthought.